Devon Still’s jersey sales set Cincinnati Bengals record, fund cancer research

Jul 26, 2014; Cincinnati, OH, USA; Cincinnati Bengals defensive tackle Devon Still (75) runs drills during training camp at Paul Brown Stadium. Mandatory Credit: Aaron Doster-USA TODAY Sports
Jul 26, 2014; Cincinnati, OH, USA; Cincinnati Bengals defensive tackle Devon Still (75) runs drills during training camp at Paul Brown Stadium. Mandatory Credit: Aaron Doster-USA TODAY Sports /
facebooktwitterreddit

No, Devon Still may not be a household name though there’s a good chance you’ve heard of the Cincinnati Bengals defensive lineman.

More from Cincinnati Bengals

Faced with a difficult roster decision, the Cincinnati Bengals decided to cut Devon Still from their 53-man roster before the season began. That’s a difficult situation for any player, especially when your four-year-old daughter is undergoing cancer treatment.

Well aware of the situation Still was dealing with, the Cincinnati Bengals had a proposition. They’d agree to sign Devon Still to a practice squad contract allowing him not only to keep his job with the team, but also allowing him to stay on the NFL insurance policy which will help pay for his daughter’s mounting medical bills. Not only that, the Cincinnati Bengals decided they would donate sales from Devon Still’s jersey to cancer research.

Normally that may not sound like a big deal considering Still’s jersey isn’t what you’d call high-profile, though it has apparently been flying off the shelves.

In fact, according to ESPN, Still’s jersey has set Cincinnati Bengals sales records.

"Less than 24 hours later, a team official told ESPN.com that more of the defensive tackle’s black No. 75 jerseys had been sold in that time span than any jersey featuring any other Bengals player ever."

How amazing is that? Not only do the Cincinnati Bengals deserve a significant amount of praise for keeping Still around during his difficult time, but fans of the organization should be proud of themselves as well given they’ve assisted in funding for cancer research.